Ultima Labs

3rd Party Tested & Certified Research Grade Peptides
RETATRUTIDE 20MG

RETATRUTIDE 20MG

$299.95 Coming Soon
ⓘ

For research purposes only. Not for human consumption.

Peptide Class R

Retatrutide 20mg — Triple Agonist Research Peptide

Retatrutide 20mg is a high-dose preparation of the synthetic triple agonist peptide targeting GLP-1, GIP, and glucagon (GCGR) receptors simultaneously. Formulated for research protocols requiring elevated compound quantities, this preparation enables extended investigations into combined receptor activation dynamics underpinning metabolic regulation, energy balance, and adipose tissue function under controlled experimental conditions.

Research Applications

Research employing Retatrutide 20mg benefits from the same tripartite receptor engagement as the 10mg preparation, offering practical advantages for longer-duration experimental designs or studies requiring larger compound quantities. Investigators have used this compound to explore mechanisms by which concurrent GLP-1, GIP, and glucagon receptor stimulation modulates downstream metabolic signalling, lipid metabolism, and energy substrate utilisation.

Formulation & Purity

Supplied as a high-purity white lyophilised powder, this product exceeds >99% purity as verified by HPLC analysis. Its freeze-dried formulation ensures long-term structural stability, maintaining peptide integrity throughout storage and transport. Researchers may reconstitute the compound using bacteriostatic water or a sterile diluent suited to their experimental protocol.

Intended Use

Retatrutide 20mg is intended exclusively for in vitro and non-clinical scientific research. It is not approved for human or animal therapeutic, diagnostic, or medicinal use. All handling and experimentation must be conducted by trained professionals within appropriate controlled laboratory environments.

Login to join the notification waitlist

Certificate of Analysis

Certificate status: This product's third-party Certificate of Analysis has been ordered and is currently in progress. The verified report will be published here once available.

Certificate of Analysis in progress - RETATRUTIDE 20MG

Pending publication of the finalized third-party laboratory report.

DISCLAIMER

Disclaimer: All products supplied by Ultima Labs are intended solely for laboratory and scientific research purposes. These products are not licensed, approved, or meant for human or animal consumption, nor for any form of therapeutic, medicinal, or diagnostic use. The information presented on this website has not undergone evaluation or approval by the Therapeutic Goods Administration (TGA) or any other regulatory authority. These compounds are not formulated to diagnose, treat, cure, or prevent any disease or health condition. Purchase is limited to qualified professionals, researchers, and authorized research institutions both within Australia and internationally. By placing an order, you acknowledge and agree to comply with these terms.